← Back to Patent Explorer
US6433159B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions and methods for treatment of Hepatitis C virus associated diseases

Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1997-03-17
•
Granted: 2002-08-13
•
Expires: 2017-03-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antisense oligonucleotides are provided which are complementary to at least a portion of HCV RNA and specifically hybridizable therewith. These oligonucleotides can be administered to inhibit the replication of Hepatitis C virus in vivo or in vitro and to treat Hepatitis C virus-associated disease. These compounds can be used either prophylactically or therapeutically to reduce the severity of diseases associated with Hepatitis C virus.

Inventors

  • 👤 Kevin P. Anderson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 12:00
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C12N15/1131; C07; C07H; C07H21/00; C07K; C07K14/00; C07K14/005; C12Q; C12Q1/00; C12Q1/70; C12Q1/701; C12Q1/706; C12Q1/707; C12N2310/00; C12N2310/30; C12N2310/31; C12N2310/315; C12N2310/33; C12N2310/35; C12N2310/352; C12N2310/3521; C12N2310/3527; C12N2770/00; C12N2770/00011; C12N2770/24011; C12N2770/24211; C12N2770/24222

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 38 words
An oligonucleotide 12-25 nucleotides in length which has a nucleotide sequence complementary to at least a portion of a polyprotein translation initiation region of HCV genomic or messenger RNA, said oligonucleotide which inhibits the translation of said RNA.
Claim 2
Dependent Claim 38 words
An oligonucleotide 12-25 nucleotides in length which has a nucleotide sequence complementary to at least a portion of a polyprotein translation initiation region of HCV genomic or messenger RNA, said oligonucleotide which inhibits the translation of said RNA.

References Cited (Backward Citations)

US5034506A Cited
EP0318216A1 Cited
EP0419182A1 Cited
US5427909A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2005-08-12 2006-02-11 2006-08-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2009-08-12 2010-02-11 2010-08-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2013-08-12 2014-02-11 2014-08-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag